Literature DB >> 30499422

Emerging Therapeutic Targets for Metabolic Syndrome: Lessons from Animal Models.

Himadri Singh1, Samuel Joshua Pragasam1, Vijayalakshmi Venkatesan1.   

Abstract

BACKGROUND: Metabolic syndrome is a cluster of medical conditions that synergistically increase the risk of heart diseases and diabetes. The current treatment strategy for metabolic syndrome focuses on treating its individual components. A highly effective agent for metabolic syndrome has yet to be developed. To develop a target for metabolic syndrome, the mechanism encompassing different organs - nervous system, pancreas, skeletal muscle, liver and adipose tissue - needs to be understood. Many animal models have been developed to understand the pathophysiology of metabolic syndrome. Promising molecular targets have emerged while characterizing these animals. Modulating these targets is expected to treat some components of metabolic syndrome.
OBJECTIVE: To discuss the emerging molecular targets in an animal model of metabolic syndrome.
METHODS: A literature search was performed for the retrieval of relevant articles.
CONCLUSION: Multiple genes/pathways that play important role in the development of Metabolic Syndrome are discussed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  NCDs; Obesity; animal models; diabetes; inflammation; metabolic syndrome.

Mesh:

Substances:

Year:  2019        PMID: 30499422     DOI: 10.2174/1871530319666181130142642

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  1 in total

1.  MH-76, a Novel Non-Quinazoline α1-Adrenoceptor Antagonist, but Not Prazosin Reduces Inflammation and Improves Insulin Signaling in Adipose Tissue of Fructose-Fed Rats.

Authors:  Monika Kubacka; Szczepan Mogilski; Monika Zadrożna; Barbara Nowak; Małgorzata Szafarz; Bartosz Pomierny; Henryk Marona; Anna Waszkielewicz; Wojciech Jawień; Jacek Sapa; Marek Bednarski; Joanna Knutelska; Magdalena Kotańska
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.